Overview
- A San Francisco law firm filed a U.S. class-action complaint accusing Oura of selling the Oura Ring as a precise sleep-stage tracker when the ring infers stages from peripheral signals such as heart rate, movement, and skin temperature.
- The suit alleges those algorithmic inferences cannot match clinical sleep studies and calls the ring’s stage outputs unreliable, arguing that true sleep stages are defined by brain activity, eye movements, and muscle tone that the ring does not record.
- Oura has formally denied the claims, saying its sleep-staging algorithms were trained on large datasets, have peer-reviewed validation, and report roughly 79% agreement with polysomnography in studies.
- Sleep experts and journalists cited by coverage say consumer wearables provide useful trend data but are not medical-grade, and they warn that overreliance on tracker numbers can drive unhealthy behaviors like orthosomnia.
- If the case is settled or decided for plaintiffs, consumers could receive partial refunds and Oura might be required to change marketing language, a result that could reshape how wearable makers describe algorithmic health outputs.